Compare AES Corp (AES) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AES Corp vs Bristol-Myers Squibb Co — how do they compare? AES Corp trades at $14.7 (market cap $10.49B), while Bristol-Myers Squibb Co trades at $63.66 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 12.4× AES Corp's market cap, and AES Corp pays the higher dividend (4.79%). Which is the better fit depends on your goals.
| AES | BMY | |
|---|---|---|
Market Cap | $10.49B | $129.94B |
Sector | Utilities | Health |
52-Week High | $17.28 | $65.89 |
52-Week Low | $12.51 | $42.60 |
Enterprise Value | $40.75B | $163.92B |
Dividend Yield | 4.79% | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AES Corp
AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.
Read more on AES →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
